Rebecca V Steenaard

6PUBLICATIONS
8CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Disease surveillancePacific Peoples cultural determinants of healthCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 01, 2026
Time trends in incidence, treatment, and survival of patients with adrenocortical carcinoma, a nationwide study.

Rebecca V Steenaard, J Sofie de Wit, Marieke Rutjens

|Apr 18, 2022
EDP-mitotane in children: reassuring evidence of reversible side-effects and neurotoxicity.

Rebecca V Steenaard, Marieke Rutjens, Madeleine H T Ettaieb

|Apr 22, 2021
How close are we to personalized mitotane dosing in the treatment of adrenocortical carcinoma? State of the art and future perspectives.

Rebecca V Steenaard, Madeleine H T Ettaieb, Thomas M A Kerkhofs

|Apr 29, 2020
Patient and Partner Perspectives on Health-Related Quality of Life in Adrenocortical Carcinoma.

Rebecca V Steenaard, Marjolein N T Kremers, Laura A Michon

|Oct 11, 2019
Health-Related Quality of Life in Adrenocortical Carcinoma.

Rebecca V Steenaard, Laura A Michon, Harm R Haak

Pageof 1